Drug Manufacturers’ Supply Options Could Be Constricted By Legislation
This article was originally published in The Tan Sheet
Executive Summary
Congressional efforts to legislate greater emphasis on drug quality, both by FDA and the industry, could render a more compact supply chain for manufacturers
You may also be interested in...
Waxman Sets Sights On Dingell’s Energy And Commerce Chair
One day after Democrats increased their number of seats in the House, Rep. Henry Waxman sent ripples across the majority with a bid to replace Rep. John Dingell as Energy and Commerce Committee chairman
Waxman Sets Sights On Dingell’s Energy And Commerce Chair
One day after Democrats increased their number of seats in the House, Rep. Henry Waxman sent ripples across the majority with a bid to replace Rep. John Dingell as Energy and Commerce Committee chairman
Waxman Sets Sights On Dingell’s Energy And Commerce Chair
One day after Democrats increased their number of seats in the House, Rep. Henry Waxman sent ripples across the majority with a bid to replace Rep. John Dingell as Energy and Commerce Committee chairman